HN2301

HN2301 · Shenzhen MagicRNA Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HN2301, covering 2026-02-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） [Phase 1]